title: Report of two children with subacute sclerosing panencephalitis displaying an atypical clinical course.
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Tepebaşili
authors.forename: Hüseyin
authors.initials: H
authors.lastname: Caksen
authors.forename: Dursun
authors.initials: D
authors.lastname: Odabaş
authors.forename: Bülent
authors.initials: B
authors.lastname: Ataş
authors.forename: Sinan
authors.initials: S
authors.lastname: Akbayram
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001037:Aphasia / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D004635:Emergency Medicine / Q000379:methods*; D017809:Fatal Outcome; D005260:Female; D020234:Gait Ataxia / Q000209:etiology; D006801:Humans; D007542:Inosine Pranobex / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use; D013344:Subacute Sclerosing Panencephalitis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons; D007542:Inosine Pranobex